Oncternal Therapeutics, Inc. (ONCT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 11:58AM EDT. Market open.
| Previous close | 8.00 |
| Open | 8.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 8.00 - 8.68 |
| 52-week range | 5.57 - 13.20 |
| Volume | |
| Avg. volume | 7,731 |
| Market cap | 25.695M |
| Beta (5Y monthly) | 1.37 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Oncternal Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
Oncternal Therapeutics ( NASDAQ:ONCT ) Full Year 2023 Results Key Financial Results Net loss: US$39.5m (loss narrowed...
- Insider Monkey
Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript
Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript November 9, 2023 Oncternal Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.15. Operator: Greetings and welcome to Oncternal Therapeutics third-quarter 2023 financial results conference call. [Operator Instructions]. As a reminder, this conference is being recorded. I would now like to […]
- Simply Wall St.
We're A Little Worried About Oncternal Therapeutics' (NASDAQ:ONCT) Cash Burn Rate
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
© 2024 Yahoo. All rights reserved.